MC230502 Dynamic Investigator Initiated Enterprise (DIVINE) in Prostate Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT06378866

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:29:07.256478+00:00

Published At

2026-04-20T00:00:00+00:00

Record Updated At

2026-04-20

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Recurrent Castration-Sensitive Prostate Carcinoma", "Recurrent Prostate Cancer", "Castration-resistant Prostate Cancer", "Biochemically Recurrent Prostate Carcinoma"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-04-20"

protocolSection.identificationModule.nctId

"NCT06378866"

protocolSection.identificationModule.officialTitle

"MC230502 Dynamic Investigator Initiated Enterprise (DIVINE) in Prostate Cancer"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Recurrent Castration-Sensitive Prostate Carcinoma (protocolSection.conditionsModule.conditions)
• Recurrent Prostate Cancer (protocolSection.conditionsModule.conditions)
• Castration-resistant Prostate Cancer (protocolSection.conditionsModule.conditions)
• Biochemically Recurrent Prostate Carcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.